Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
35 studies found for:    Open Studies | "Gastritis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Gastritis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis
Condition: Gastritis
Interventions: Drug: GC6101A 37.5mg;   Drug: GC6101A 75mg;   Drug: GC6101A 150mg;   Drug: Placebo
2 Not yet recruiting The Study of Chinese Medicine for the Treatment of Chronic Atrophic Gastritis
Condition: Chronic Atrophic Gastritis
Interventions: Drug: Talcid®;   Drug: Chinese medicine prescription;   Drug: Placebo;   Drug: Compound Azimtamide Entieric-coated Tablets
3 Recruiting Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea
Condition: Atrophic Gastritis
Intervention: Drug: pepsinogen and gastrin
4 Recruiting Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Conditions: Gastroenteritis;   Gastritis
Intervention: Drug: RHB-102
5 Not yet recruiting Linked Color Imaging/Magnifying Blue Laser Imaging to Differentiate H. Pylori Associated Gastritis and Gastric Atrophy
Conditions: Gastritis;   Helicobacter Pylori Associated Gastritis;   Atrophic Gastritis
Intervention: Device: Digital chromoendoscopy and magnification
6 Recruiting Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients
Conditions: Helicobacter Pylori Infection;   Atrophic Gastritis;   Intestinal Metaplasia
Intervention:
7 Not yet recruiting A Multi-center Study for Eradication of Helicobacter Pylori With Triple Therapy Using Clarithromycin
Condition: Gastritis
Interventions: Device: The results of clarithromycin susceptibility test of H. pylori isolates;   Device: Computer generated random number, randomly assigned into groups;   Device: The result of 13C-urea breath test of patient in 7days/10days/14days treatment groups
8 Recruiting A Multi-center Study for Eradication of Refractory Helicobacter Pylori
Condition: Gastritis
Interventions: Device: The result of H pylori culture based on gram staining and enzyme activity testing;   Device: The result of 13C-urea breath test after treatment based on the selection of clarithromycin, levofloxacin, metronidazole, amoxicillin,tetracycline,furazolidone and the dose of esomeprazole;   Device: The result of Amoxicillin resistance in vitro based on antibiotic susceptibility testing
9 Recruiting i-Scan for the Detection of Helicobacter Pylori
Condition: Gastritis
Interventions: Device: i-scan;   Device: narrow band imaging
10 Not yet recruiting Phase 2a Study to Evaluate Optimum Dosage and Stability of DW-3101 in Gastric Inflammation Patients
Condition: Acute and Chronic Gastric Inflammation Patients
Interventions: Drug: DW-3101_150mg;   Drug: DW-3101_300mg;   Drug: DW-3101_600mg;   Drug: Placebo
11 Recruiting A Relevance Study Between the Result of Clinical Drug Intervention and Next-generation Sequencing Technology Focused on Refractory Helicobacter Pylori Infection
Condition: Gastritis
Interventions: Device: The eradication times of the patients;   Device: The result of 13C-urea breath test after treatment
12 Recruiting Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori
Condition: Helicobacter-associated Gastritis
Interventions: Drug: Nitazoxanide;   Drug: Metronidazole(MTZ);   Drug: Omeprazole;   Drug: Clarithromycin;   Drug: Levofloxacin;   Drug: Doxicycline
13 Not yet recruiting Comparison of Vonoprazan-based Dual and Triple Therapies for H. Pylori Eradication
Condition: Gastritis Associated With Helicobacter Pylori
Interventions: Drug: vonoprazan 20 mg bid;   Drug: Amoxicillin 500 mg tid;   Drug: Amoxicillin 750 mg bid;   Drug: Clarithromycin 200 mg bid;   Drug: Metronidazole 250 mg bid
14 Not yet recruiting Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia
Conditions: Chronic Atrophic Gastritis;   Intestinal Metaplasia of Gastric Mucosa
Interventions: Drug: Curcumin;   Other: Laboratory Biomarker Analysis;   Other: Placebo;   Other: Quality-of-Life Assessment
15 Recruiting Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Conditions: Eosinophilic Esophagitis;   Eosinophilic Gastritis;   Eosinophilic Gastroenteritis;   Eosinophilic Colitis
Intervention:
16 Recruiting Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
Conditions: Gastritis;   Gastroduodenal Ulcer
Interventions: Drug: ALBIS;   Drug: Placebo
17 Not yet recruiting System Biology of Spleen Deficiency Syndrome
Conditions: Gastritis, Atrophic;   Gastric Cancer
Intervention:
18 Not yet recruiting A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection
Conditions: Gastritis;   Gastric Ulcer
Interventions: Biological: Antibiotic selection based on the antibiotic susceptibility testing;   Genetic: PPI selection based on the CYP2C19 gene polymorphism;   Dietary Supplement: Probiotics usage based on the 16SrRNA sequencing
19 Recruiting OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
Conditions: Eosinophilic Gastrointestinal Disorders (EGIDs);   Eosinophilic Esophagitis;   Eosinophilic Gastritis;   Eosinophilic Colitis
Intervention:
20 Recruiting Gastric Cancer Screening Quality Improvement System Establishment
Conditions: Gastric Cancer;   Gastritis, Atrophic;   Intestinal Metaplasia
Intervention: Behavioral: Education and feedback

   Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.